The researchers also demonstrated the presence of several different ICs (including PD-L1) on the surface of CLL EVs and suggested that this might explain the failure of CAR-T-cell therapy and anti-PD-1/PD-L1 therapy in CLL. Here, CD274 is linked to B-cell chronic lymphocytic leukemia.